Public Policy

For Immediate Release: August 5, 2024, 11:30 a.m. U.S. Eastern Time Media Contact: Kara Flynn, (202) 257-8424, press@ashg.org American Society of Human Genetics (ASHG) President Bruce D. Gelb, M.D., released the following statement in response to the U.S. Senate Appropriations Committee’s approval by a 25-3 vote of the fiscal year (FY) 2025 bill for the... Read More

In May 2024, ASHG hosted a fourth year of virtual advocacy meetings with policymakers on Capitol Hill. Over the course of a week, participants in the  2024 cohort of the Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program joined members of past  ACGT  cohorts and members of the  Government and Public Advocacy Committee (GPAC)  in meetings with 15 congressional... Read More

For the benefits of human genetics and genomics research to be realized by all people, research studies must reflect humanity’s diversity. This will take a concerted effort by the research community and greater engagement with individuals and communities underrepresented in research. Policymakers play a pivotal role in shaping the landscape of genetic research, healthcare, and... Read More

ASHG recently spoke with Julie Gerberding, MD, MPH, President and CEO of the Foundation for the National Institutes of Health (FNIH), on how this organization leverages expertise across a breadth of scientific industries to address complex health challenges and accelerate research, particularly in human genetics and genomics.  The FNIH is an independent, not-for-profit 501(c)(3) charitable... Read More

In May 2023, ASHG hosted a third year of virtual advocacy meetings with policymakers on Capitol Hill. The week-long event brought together trainee advocates from both the 2022 and the 2023 Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program. Participation in this spring advocacy activity is a key feature of the ACGT program.... Read More